Original Article

Creatinine Excretion as a Determinant of Accelerated Skeletal Muscle Loss with Critical Illness

10.5152/TJAR.2018.60437

  • Jehanzeb Khan
  • Khushbir Bath
  • Fareeha Hafeez
  • Gayoung Kim
  • Gene R. Pesola

Received Date: 13.01.2017 Accepted Date: 09.02.2018 Turk J Anaesthesiol Reanim 2018;46(4):311-315

Objective:

The 24-h urinary creatinine excretion rate has been used as an approximation of the skeletal muscle (SM) mass in non-intensive care unit (ICU) settings. The study goal or aim was to determine reductions in SM mass in patients with recurrent critical illness who are admitted to a medical ICU.

Methods:

Retrospective ICU patient records between 2013 and 2015 were reviewed. Inclusion of ICU patients with repeat 24-h urinary creatinine excretion levels at two different ICU admissions done routinely as part of care. The study design is a case series with patients as their own control.

Results:

Three patients were found to have data on two separate ICU admissions. The reduction in creatinine excretion among ICU patients was correlated with estimated SM mass. All patients had >50% reduction in creatinine excretion and ≥47% reduction in estimated SM mass over 4 months. All patients were bed-bound after the first ICU admission and met the definition of sarcopenia by the second ICU admission; all patients died during the second ICU admission. The final SM mass in all patients was <4 kg m-2.

Conclusion:

Patients with chronic critical illness admitted to the medical ICU, who become bed bound, can experience up to 50% reduction in SM mass as gleaned from creatinine excretion within 4 months. Low SM mass may predispose patients to increased mortality. Measurement of 24-h urinary creatinine excretion may be a useful ICU biomarker to determine SM mass for diagnostic and prognostic purposes.

Keywords: Creatinine excretion and muscle mass, muscle mass and ICU mortality, sarcopenia and ICU mortality, BMI and body composition